nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—KCNJ11—Verapamil—migraine	0.246	0.365	CbGbCtD
Gliclazide—ALB—Amitriptyline—migraine	0.0676	0.1	CbGbCtD
Gliclazide—CYP2C19—Timolol—migraine	0.0568	0.0843	CbGbCtD
Gliclazide—CYP2C19—Propranolol—migraine	0.0507	0.0751	CbGbCtD
Gliclazide—CYP2C19—Amitriptyline—migraine	0.0438	0.065	CbGbCtD
Gliclazide—CYP2C19—Valproic Acid—migraine	0.0399	0.0592	CbGbCtD
Gliclazide—CYP2C9—Amitriptyline—migraine	0.0364	0.054	CbGbCtD
Gliclazide—CYP2C19—Topiramate—migraine	0.036	0.0534	CbGbCtD
Gliclazide—CYP2C19—Verapamil—migraine	0.0348	0.0516	CbGbCtD
Gliclazide—CYP2C9—Valproic Acid—migraine	0.0332	0.0492	CbGbCtD
Gliclazide—CYP2C9—Verapamil—migraine	0.0289	0.0429	CbGbCtD
Gliclazide—KCNJ11—Type II diabetes mellitus—CACNA1A—migraine	0.00332	0.101	CbGpPWpGaD
Gliclazide—VEGFA—Pindolol—Propranolol—migraine	0.00315	1	CbGdCrCtD
Gliclazide—ABCC8—Potassium Channels—KCNK18—migraine	0.00211	0.0642	CbGpPWpGaD
Gliclazide—KCNJ11—Potassium Channels—KCNK18—migraine	0.00204	0.0622	CbGpPWpGaD
Gliclazide—ALB—Scavenging of heme from plasma—LRP1—migraine	0.00132	0.0402	CbGpPWpGaD
Gliclazide—ABCC8—Regulation of insulin secretion—CACNA1A—migraine	0.00126	0.0383	CbGpPWpGaD
Gliclazide—KCNJ11—Regulation of insulin secretion—CACNA1A—migraine	0.00122	0.0371	CbGpPWpGaD
Gliclazide—VEGFA—Glypican 1 network—TGFBR2—migraine	0.00112	0.034	CbGpPWpGaD
Gliclazide—VEGFA—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.00107	0.0326	CbGpPWpGaD
Gliclazide—ABCC8—Integration of energy metabolism—CACNA1A—migraine	0.000989	0.0301	CbGpPWpGaD
Gliclazide—KCNJ11—Integration of energy metabolism—CACNA1A—migraine	0.000959	0.0292	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—KCNK18—migraine	0.00092	0.028	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000904	0.0275	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—KCNK18—migraine	0.000892	0.0272	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—HTR3A—migraine	0.000768	0.0234	CbGpPWpGaD
Gliclazide—VEGFA—Beta3 integrin cell surface interactions—TGFBR2—migraine	0.000746	0.0227	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—BDNF—migraine	0.000565	0.0172	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—TGFBR2—migraine	0.00055	0.0167	CbGpPWpGaD
Gliclazide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.000527	0.016	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—ESR1—migraine	0.00051	0.0155	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—SCN1A—migraine	0.000504	0.0153	CbGpPWpGaD
Gliclazide—KCNJ11—Type II diabetes mellitus—TNF—migraine	0.000473	0.0144	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—CACNA1A—migraine	0.000449	0.0137	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—TRPM8—migraine	0.000441	0.0134	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—CACNA1A—migraine	0.000436	0.0133	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—SCN2A—migraine	0.000428	0.013	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—HTR1A—migraine	0.000365	0.0111	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TAC1—migraine	0.00036	0.011	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—SCN1A—migraine	0.000359	0.0109	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000353	0.0107	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—FOS—migraine	0.000349	0.0106	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—FOS—migraine	0.000345	0.0105	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ATP1A3—migraine	0.000334	0.0102	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ATP1A2—migraine	0.000334	0.0102	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—SCN2A—migraine	0.000306	0.00931	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—HTR3A—migraine	0.000284	0.00865	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—MEF2D—migraine	0.00028	0.00851	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000273	0.00832	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—BDNF—migraine	0.000256	0.0078	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—TNF—migraine	0.000247	0.00753	CbGpPWpGaD
Gliclazide—Asthenia—Propranolol—migraine	0.000225	0.000776	CcSEcCtD
Gliclazide—Pneumonia—Topiramate—migraine	0.000225	0.000776	CcSEcCtD
Gliclazide—Mental disorder—Timolol—migraine	0.000224	0.000775	CcSEcCtD
Gliclazide—Leukopenia—Valproic Acid—migraine	0.000224	0.000774	CcSEcCtD
Gliclazide—Malnutrition—Timolol—migraine	0.000223	0.00077	CcSEcCtD
Gliclazide—Erythema—Timolol—migraine	0.000223	0.00077	CcSEcCtD
Gliclazide—Eye disorder—Gabapentin—migraine	0.000223	0.00077	CcSEcCtD
Gliclazide—Depression—Topiramate—migraine	0.000223	0.000769	CcSEcCtD
Gliclazide—Tinnitus—Gabapentin—migraine	0.000222	0.000768	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Topiramate—migraine	0.000222	0.000765	CcSEcCtD
Gliclazide—Palpitations—Valproic Acid—migraine	0.000221	0.000764	CcSEcCtD
Gliclazide—Renal failure—Topiramate—migraine	0.00022	0.000759	CcSEcCtD
Gliclazide—Neuropathy peripheral—Topiramate—migraine	0.000219	0.000756	CcSEcCtD
Gliclazide—Tension—Timolol—migraine	0.000219	0.000755	CcSEcCtD
Gliclazide—Cough—Valproic Acid—migraine	0.000219	0.000755	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000218	0.00663	CbGpPWpGaD
Gliclazide—Conjunctivitis—Topiramate—migraine	0.000217	0.00075	CcSEcCtD
Gliclazide—Urinary tract infection—Topiramate—migraine	0.000217	0.00075	CcSEcCtD
Gliclazide—Nervousness—Timolol—migraine	0.000217	0.000748	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—HTR2A—migraine	0.000216	0.00659	CbGpPWpGaD
Gliclazide—Hypertension—Valproic Acid—migraine	0.000216	0.000747	CcSEcCtD
Gliclazide—Diarrhoea—Propranolol—migraine	0.000215	0.00074	CcSEcCtD
Gliclazide—Chills—Gabapentin—migraine	0.000214	0.000739	CcSEcCtD
Gliclazide—Chest pain—Valproic Acid—migraine	0.000213	0.000736	CcSEcCtD
Gliclazide—Arthralgia—Valproic Acid—migraine	0.000213	0.000736	CcSEcCtD
Gliclazide—Myalgia—Valproic Acid—migraine	0.000213	0.000736	CcSEcCtD
Gliclazide—Anxiety—Valproic Acid—migraine	0.000213	0.000734	CcSEcCtD
Gliclazide—Hypersensitivity—Verapamil—migraine	0.000212	0.000733	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000212	0.000731	CcSEcCtD
Gliclazide—Epistaxis—Topiramate—migraine	0.000211	0.000728	CcSEcCtD
Gliclazide—Discomfort—Valproic Acid—migraine	0.000211	0.000727	CcSEcCtD
Gliclazide—Sinusitis—Topiramate—migraine	0.00021	0.000724	CcSEcCtD
Gliclazide—Mental disorder—Gabapentin—migraine	0.000209	0.000721	CcSEcCtD
Gliclazide—Agranulocytosis—Topiramate—migraine	0.000209	0.00072	CcSEcCtD
Gliclazide—Dry mouth—Valproic Acid—migraine	0.000209	0.00072	CcSEcCtD
Gliclazide—Malnutrition—Gabapentin—migraine	0.000208	0.000717	CcSEcCtD
Gliclazide—Erythema—Gabapentin—migraine	0.000208	0.000717	CcSEcCtD
Gliclazide—Dizziness—Propranolol—migraine	0.000207	0.000715	CcSEcCtD
Gliclazide—Asthenia—Verapamil—migraine	0.000207	0.000714	CcSEcCtD
Gliclazide—Confusional state—Valproic Acid—migraine	0.000206	0.000712	CcSEcCtD
Gliclazide—Flatulence—Gabapentin—migraine	0.000205	0.000706	CcSEcCtD
Gliclazide—Bradycardia—Topiramate—migraine	0.000204	0.000705	CcSEcCtD
Gliclazide—Pruritus—Verapamil—migraine	0.000204	0.000704	CcSEcCtD
Gliclazide—Tension—Gabapentin—migraine	0.000204	0.000703	CcSEcCtD
Gliclazide—Angioedema—Timolol—migraine	0.000204	0.000703	CcSEcCtD
Gliclazide—Infection—Valproic Acid—migraine	0.000203	0.000701	CcSEcCtD
Gliclazide—Nervousness—Gabapentin—migraine	0.000202	0.000696	CcSEcCtD
Gliclazide—Rhinitis—Topiramate—migraine	0.000201	0.000695	CcSEcCtD
Gliclazide—Back pain—Gabapentin—migraine	0.000201	0.000693	CcSEcCtD
Gliclazide—Hepatitis—Topiramate—migraine	0.000201	0.000693	CcSEcCtD
Gliclazide—Nervous system disorder—Valproic Acid—migraine	0.000201	0.000692	CcSEcCtD
Gliclazide—Thrombocytopenia—Valproic Acid—migraine	0.0002	0.000691	CcSEcCtD
Gliclazide—Hypoaesthesia—Topiramate—migraine	0.0002	0.000689	CcSEcCtD
Gliclazide—Tachycardia—Valproic Acid—migraine	0.0002	0.000689	CcSEcCtD
Gliclazide—Vomiting—Propranolol—migraine	0.000199	0.000688	CcSEcCtD
Gliclazide—Pharyngitis—Topiramate—migraine	0.000199	0.000688	CcSEcCtD
Gliclazide—Skin disorder—Valproic Acid—migraine	0.000199	0.000685	CcSEcCtD
Gliclazide—Oedema peripheral—Topiramate—migraine	0.000198	0.000682	CcSEcCtD
Gliclazide—Hyperhidrosis—Valproic Acid—migraine	0.000198	0.000682	CcSEcCtD
Gliclazide—Rash—Propranolol—migraine	0.000198	0.000682	CcSEcCtD
Gliclazide—Dermatitis—Propranolol—migraine	0.000198	0.000682	CcSEcCtD
Gliclazide—Diarrhoea—Verapamil—migraine	0.000197	0.000681	CcSEcCtD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—ESR1—migraine	0.000197	0.006	CbGpPWpGaD
Gliclazide—Palpitations—Timolol—migraine	0.000197	0.00068	CcSEcCtD
Gliclazide—Loss of consciousness—Timolol—migraine	0.000196	0.000677	CcSEcCtD
Gliclazide—Cough—Timolol—migraine	0.000195	0.000672	CcSEcCtD
Gliclazide—Tremor—Gabapentin—migraine	0.000195	0.000672	CcSEcCtD
Gliclazide—Visual impairment—Topiramate—migraine	0.000193	0.000668	CcSEcCtD
Gliclazide—Ill-defined disorder—Gabapentin—migraine	0.000193	0.000665	CcSEcCtD
Gliclazide—Hypertension—Timolol—migraine	0.000193	0.000665	CcSEcCtD
Gliclazide—Anaemia—Gabapentin—migraine	0.000192	0.000663	CcSEcCtD
Gliclazide—Hypotension—Valproic Acid—migraine	0.000191	0.000659	CcSEcCtD
Gliclazide—Agitation—Gabapentin—migraine	0.000191	0.000659	CcSEcCtD
Gliclazide—Dizziness—Verapamil—migraine	0.000191	0.000658	CcSEcCtD
Gliclazide—Chest pain—Timolol—migraine	0.00019	0.000655	CcSEcCtD
Gliclazide—Arthralgia—Timolol—migraine	0.00019	0.000655	CcSEcCtD
Gliclazide—Myalgia—Timolol—migraine	0.00019	0.000655	CcSEcCtD
Gliclazide—Erythema multiforme—Topiramate—migraine	0.00019	0.000655	CcSEcCtD
Gliclazide—Angioedema—Gabapentin—migraine	0.00019	0.000655	CcSEcCtD
Gliclazide—Anxiety—Timolol—migraine	0.000189	0.000653	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000189	0.000651	CcSEcCtD
Gliclazide—Discomfort—Timolol—migraine	0.000188	0.000647	CcSEcCtD
Gliclazide—Eye disorder—Topiramate—migraine	0.000188	0.000647	CcSEcCtD
Gliclazide—Malaise—Gabapentin—migraine	0.000187	0.000646	CcSEcCtD
Gliclazide—Tinnitus—Topiramate—migraine	0.000187	0.000646	CcSEcCtD
Gliclazide—ALB—Vitamin B12 Metabolism—MTHFR—migraine	0.000187	0.00568	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Valproic Acid—migraine	0.000186	0.000643	CcSEcCtD
Gliclazide—Flushing—Topiramate—migraine	0.000186	0.000643	CcSEcCtD
Gliclazide—Nausea—Propranolol—migraine	0.000186	0.000643	CcSEcCtD
Gliclazide—Leukopenia—Gabapentin—migraine	0.000186	0.000642	CcSEcCtD
Gliclazide—Dry mouth—Timolol—migraine	0.000186	0.000641	CcSEcCtD
Gliclazide—Insomnia—Valproic Acid—migraine	0.000185	0.000638	CcSEcCtD
Gliclazide—Paraesthesia—Valproic Acid—migraine	0.000184	0.000634	CcSEcCtD
Gliclazide—Palpitations—Gabapentin—migraine	0.000184	0.000633	CcSEcCtD
Gliclazide—Confusional state—Timolol—migraine	0.000184	0.000633	CcSEcCtD
Gliclazide—Vomiting—Verapamil—migraine	0.000183	0.000633	CcSEcCtD
Gliclazide—Loss of consciousness—Gabapentin—migraine	0.000183	0.00063	CcSEcCtD
Gliclazide—Dyspnoea—Valproic Acid—migraine	0.000182	0.000629	CcSEcCtD
Gliclazide—Rash—Verapamil—migraine	0.000182	0.000628	CcSEcCtD
Gliclazide—Somnolence—Valproic Acid—migraine	0.000182	0.000627	CcSEcCtD
Gliclazide—Dermatitis—Verapamil—migraine	0.000182	0.000627	CcSEcCtD
Gliclazide—Cough—Gabapentin—migraine	0.000181	0.000626	CcSEcCtD
Gliclazide—Infection—Timolol—migraine	0.000181	0.000624	CcSEcCtD
Gliclazide—Headache—Verapamil—migraine	0.000181	0.000624	CcSEcCtD
Gliclazide—Chills—Topiramate—migraine	0.00018	0.000622	CcSEcCtD
Gliclazide—Dyspepsia—Valproic Acid—migraine	0.00018	0.000621	CcSEcCtD
Gliclazide—Convulsion—Gabapentin—migraine	0.00018	0.000621	CcSEcCtD
Gliclazide—Hypertension—Gabapentin—migraine	0.000179	0.000619	CcSEcCtD
Gliclazide—Nervous system disorder—Timolol—migraine	0.000179	0.000616	CcSEcCtD
Gliclazide—Chest pain—Gabapentin—migraine	0.000177	0.00061	CcSEcCtD
Gliclazide—Myalgia—Gabapentin—migraine	0.000177	0.00061	CcSEcCtD
Gliclazide—Arthralgia—Gabapentin—migraine	0.000177	0.00061	CcSEcCtD
Gliclazide—Skin disorder—Timolol—migraine	0.000177	0.00061	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Valproic Acid—migraine	0.000177	0.000609	CcSEcCtD
Gliclazide—Fatigue—Valproic Acid—migraine	0.000176	0.000608	CcSEcCtD
Gliclazide—Anxiety—Gabapentin—migraine	0.000176	0.000608	CcSEcCtD
Gliclazide—Hyperhidrosis—Timolol—migraine	0.000176	0.000607	CcSEcCtD
Gliclazide—Mental disorder—Topiramate—migraine	0.000176	0.000607	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000176	0.000606	CcSEcCtD
Gliclazide—Constipation—Valproic Acid—migraine	0.000175	0.000603	CcSEcCtD
Gliclazide—Pain—Valproic Acid—migraine	0.000175	0.000603	CcSEcCtD
Gliclazide—Malnutrition—Topiramate—migraine	0.000175	0.000603	CcSEcCtD
Gliclazide—Erythema—Topiramate—migraine	0.000175	0.000603	CcSEcCtD
Gliclazide—Discomfort—Gabapentin—migraine	0.000175	0.000603	CcSEcCtD
Gliclazide—Dry mouth—Gabapentin—migraine	0.000173	0.000597	CcSEcCtD
Gliclazide—Flatulence—Topiramate—migraine	0.000172	0.000594	CcSEcCtD
Gliclazide—Tension—Topiramate—migraine	0.000171	0.000592	CcSEcCtD
Gliclazide—Nausea—Verapamil—migraine	0.000171	0.000591	CcSEcCtD
Gliclazide—Confusional state—Gabapentin—migraine	0.000171	0.00059	CcSEcCtD
Gliclazide—Hypotension—Timolol—migraine	0.00017	0.000587	CcSEcCtD
Gliclazide—Nervousness—Topiramate—migraine	0.00017	0.000586	CcSEcCtD
Gliclazide—Back pain—Topiramate—migraine	0.000169	0.000583	CcSEcCtD
Gliclazide—Feeling abnormal—Valproic Acid—migraine	0.000169	0.000582	CcSEcCtD
Gliclazide—Infection—Gabapentin—migraine	0.000168	0.000581	CcSEcCtD
Gliclazide—Gastrointestinal pain—Valproic Acid—migraine	0.000167	0.000577	CcSEcCtD
Gliclazide—Nervous system disorder—Gabapentin—migraine	0.000166	0.000574	CcSEcCtD
Gliclazide—Thrombocytopenia—Gabapentin—migraine	0.000166	0.000573	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Timolol—migraine	0.000166	0.000572	CcSEcCtD
Gliclazide—Tachycardia—Gabapentin—migraine	0.000165	0.000571	CcSEcCtD
Gliclazide—Skin disorder—Gabapentin—migraine	0.000165	0.000568	CcSEcCtD
Gliclazide—Insomnia—Timolol—migraine	0.000165	0.000568	CcSEcCtD
Gliclazide—Hyperhidrosis—Gabapentin—migraine	0.000164	0.000566	CcSEcCtD
Gliclazide—Tremor—Topiramate—migraine	0.000164	0.000565	CcSEcCtD
Gliclazide—Paraesthesia—Timolol—migraine	0.000163	0.000564	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000163	0.00498	CbGpPWpGaD
Gliclazide—Urticaria—Valproic Acid—migraine	0.000162	0.000561	CcSEcCtD
Gliclazide—Dyspnoea—Timolol—migraine	0.000162	0.00056	CcSEcCtD
Gliclazide—Ill-defined disorder—Topiramate—migraine	0.000162	0.00056	CcSEcCtD
Gliclazide—Somnolence—Timolol—migraine	0.000162	0.000558	CcSEcCtD
Gliclazide—Abdominal pain—Valproic Acid—migraine	0.000162	0.000558	CcSEcCtD
Gliclazide—Body temperature increased—Valproic Acid—migraine	0.000162	0.000558	CcSEcCtD
Gliclazide—Anaemia—Topiramate—migraine	0.000162	0.000557	CcSEcCtD
Gliclazide—Agitation—Topiramate—migraine	0.000161	0.000554	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—TNF—migraine	0.00016	0.00488	CbGpPWpGaD
Gliclazide—Dyspepsia—Timolol—migraine	0.00016	0.000553	CcSEcCtD
Gliclazide—Hypotension—Gabapentin—migraine	0.000158	0.000547	CcSEcCtD
Gliclazide—Malaise—Topiramate—migraine	0.000158	0.000544	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Timolol—migraine	0.000157	0.000542	CcSEcCtD
Gliclazide—Fatigue—Timolol—migraine	0.000157	0.000542	CcSEcCtD
Gliclazide—Leukopenia—Topiramate—migraine	0.000156	0.00054	CcSEcCtD
Gliclazide—Pain—Timolol—migraine	0.000156	0.000537	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Gabapentin—migraine	0.000154	0.000533	CcSEcCtD
Gliclazide—Palpitations—Topiramate—migraine	0.000154	0.000533	CcSEcCtD
Gliclazide—Loss of consciousness—Topiramate—migraine	0.000154	0.00053	CcSEcCtD
Gliclazide—Insomnia—Gabapentin—migraine	0.000153	0.000529	CcSEcCtD
Gliclazide—Cough—Topiramate—migraine	0.000152	0.000526	CcSEcCtD
Gliclazide—Paraesthesia—Gabapentin—migraine	0.000152	0.000525	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—MTHFR—migraine	0.000152	0.00462	CbGpPWpGaD
Gliclazide—Convulsion—Topiramate—migraine	0.000151	0.000523	CcSEcCtD
Gliclazide—Dyspnoea—Gabapentin—migraine	0.000151	0.000522	CcSEcCtD
Gliclazide—Hypertension—Topiramate—migraine	0.000151	0.000521	CcSEcCtD
Gliclazide—Somnolence—Gabapentin—migraine	0.000151	0.00052	CcSEcCtD
Gliclazide—Hypersensitivity—Valproic Acid—migraine	0.000151	0.00052	CcSEcCtD
Gliclazide—Feeling abnormal—Timolol—migraine	0.00015	0.000518	CcSEcCtD
Gliclazide—Dyspepsia—Gabapentin—migraine	0.000149	0.000515	CcSEcCtD
Gliclazide—Gastrointestinal pain—Timolol—migraine	0.000149	0.000514	CcSEcCtD
Gliclazide—Arthralgia—Topiramate—migraine	0.000149	0.000513	CcSEcCtD
Gliclazide—Chest pain—Topiramate—migraine	0.000149	0.000513	CcSEcCtD
Gliclazide—Myalgia—Topiramate—migraine	0.000149	0.000513	CcSEcCtD
Gliclazide—Anxiety—Topiramate—migraine	0.000148	0.000512	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000148	0.00051	CcSEcCtD
Gliclazide—Discomfort—Topiramate—migraine	0.000147	0.000507	CcSEcCtD
Gliclazide—Asthenia—Valproic Acid—migraine	0.000147	0.000506	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Gabapentin—migraine	0.000146	0.000505	CcSEcCtD
Gliclazide—Fatigue—Gabapentin—migraine	0.000146	0.000504	CcSEcCtD
Gliclazide—Dry mouth—Topiramate—migraine	0.000146	0.000502	CcSEcCtD
Gliclazide—Pain—Gabapentin—migraine	0.000145	0.0005	CcSEcCtD
Gliclazide—Constipation—Gabapentin—migraine	0.000145	0.0005	CcSEcCtD
Gliclazide—Pruritus—Valproic Acid—migraine	0.000145	0.000499	CcSEcCtD
Gliclazide—Urticaria—Timolol—migraine	0.000145	0.000499	CcSEcCtD
Gliclazide—Abdominal pain—Timolol—migraine	0.000144	0.000497	CcSEcCtD
Gliclazide—Body temperature increased—Timolol—migraine	0.000144	0.000497	CcSEcCtD
Gliclazide—Confusional state—Topiramate—migraine	0.000144	0.000496	CcSEcCtD
Gliclazide—ALB—Transmembrane transport of small molecules—TRPM8—migraine	0.000142	0.00433	CbGpPWpGaD
Gliclazide—Infection—Topiramate—migraine	0.000142	0.000489	CcSEcCtD
Gliclazide—Diarrhoea—Valproic Acid—migraine	0.00014	0.000483	CcSEcCtD
Gliclazide—Nervous system disorder—Topiramate—migraine	0.00014	0.000483	CcSEcCtD
Gliclazide—Feeling abnormal—Gabapentin—migraine	0.00014	0.000482	CcSEcCtD
Gliclazide—Thrombocytopenia—Topiramate—migraine	0.00014	0.000482	CcSEcCtD
Gliclazide—Tachycardia—Topiramate—migraine	0.000139	0.00048	CcSEcCtD
Gliclazide—Gastrointestinal pain—Gabapentin—migraine	0.000139	0.000478	CcSEcCtD
Gliclazide—Skin disorder—Topiramate—migraine	0.000139	0.000478	CcSEcCtD
Gliclazide—Hyperhidrosis—Topiramate—migraine	0.000138	0.000476	CcSEcCtD
Gliclazide—Dizziness—Valproic Acid—migraine	0.000135	0.000467	CcSEcCtD
Gliclazide—Urticaria—Gabapentin—migraine	0.000135	0.000465	CcSEcCtD
Gliclazide—Hypersensitivity—Timolol—migraine	0.000134	0.000463	CcSEcCtD
Gliclazide—Abdominal pain—Gabapentin—migraine	0.000134	0.000462	CcSEcCtD
Gliclazide—Body temperature increased—Gabapentin—migraine	0.000134	0.000462	CcSEcCtD
Gliclazide—Hypotension—Topiramate—migraine	0.000133	0.00046	CcSEcCtD
Gliclazide—Asthenia—Timolol—migraine	0.000131	0.000451	CcSEcCtD
Gliclazide—Vomiting—Valproic Acid—migraine	0.00013	0.000449	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Topiramate—migraine	0.00013	0.000448	CcSEcCtD
Gliclazide—Insomnia—Topiramate—migraine	0.000129	0.000445	CcSEcCtD
Gliclazide—Rash—Valproic Acid—migraine	0.000129	0.000445	CcSEcCtD
Gliclazide—Dermatitis—Valproic Acid—migraine	0.000129	0.000445	CcSEcCtD
Gliclazide—Pruritus—Timolol—migraine	0.000129	0.000444	CcSEcCtD
Gliclazide—Headache—Valproic Acid—migraine	0.000128	0.000442	CcSEcCtD
Gliclazide—Paraesthesia—Topiramate—migraine	0.000128	0.000442	CcSEcCtD
Gliclazide—Dyspnoea—Topiramate—migraine	0.000127	0.000439	CcSEcCtD
Gliclazide—Somnolence—Topiramate—migraine	0.000127	0.000438	CcSEcCtD
Gliclazide—Dyspepsia—Topiramate—migraine	0.000126	0.000433	CcSEcCtD
Gliclazide—Hypersensitivity—Gabapentin—migraine	0.000125	0.000431	CcSEcCtD
Gliclazide—Diarrhoea—Timolol—migraine	0.000125	0.00043	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Topiramate—migraine	0.000123	0.000425	CcSEcCtD
Gliclazide—Fatigue—Topiramate—migraine	0.000123	0.000424	CcSEcCtD
Gliclazide—Constipation—Topiramate—migraine	0.000122	0.000421	CcSEcCtD
Gliclazide—Pain—Topiramate—migraine	0.000122	0.000421	CcSEcCtD
Gliclazide—Asthenia—Gabapentin—migraine	0.000122	0.00042	CcSEcCtD
Gliclazide—Nausea—Valproic Acid—migraine	0.000121	0.000419	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—MTHFR—migraine	0.000121	0.00367	CbGpPWpGaD
Gliclazide—Dizziness—Timolol—migraine	0.00012	0.000415	CcSEcCtD
Gliclazide—Pruritus—Gabapentin—migraine	0.00012	0.000414	CcSEcCtD
Gliclazide—Feeling abnormal—Topiramate—migraine	0.000118	0.000406	CcSEcCtD
Gliclazide—Gastrointestinal pain—Topiramate—migraine	0.000117	0.000402	CcSEcCtD
Gliclazide—Diarrhoea—Gabapentin—migraine	0.000116	0.0004	CcSEcCtD
Gliclazide—Vomiting—Timolol—migraine	0.000116	0.000399	CcSEcCtD
Gliclazide—Rash—Timolol—migraine	0.000115	0.000396	CcSEcCtD
Gliclazide—Dermatitis—Timolol—migraine	0.000115	0.000396	CcSEcCtD
Gliclazide—Headache—Timolol—migraine	0.000114	0.000394	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—RAMP1—migraine	0.000114	0.00347	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CALCRL—migraine	0.000114	0.00347	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—FOS—migraine	0.000114	0.00346	CbGpPWpGaD
Gliclazide—Urticaria—Topiramate—migraine	0.000113	0.000391	CcSEcCtD
Gliclazide—ABCC8—Metabolism—CACNA1A—migraine	0.000113	0.00344	CbGpPWpGaD
Gliclazide—Abdominal pain—Topiramate—migraine	0.000113	0.000389	CcSEcCtD
Gliclazide—Body temperature increased—Topiramate—migraine	0.000113	0.000389	CcSEcCtD
Gliclazide—Dizziness—Gabapentin—migraine	0.000112	0.000387	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—CACNA1A—migraine	0.00011	0.00334	CbGpPWpGaD
Gliclazide—Nausea—Timolol—migraine	0.000108	0.000373	CcSEcCtD
Gliclazide—Vomiting—Gabapentin—migraine	0.000108	0.000372	CcSEcCtD
Gliclazide—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	0.000108	0.00328	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	0.000108	0.00328	CbGpPWpGaD
Gliclazide—Rash—Gabapentin—migraine	0.000107	0.000369	CcSEcCtD
Gliclazide—Dermatitis—Gabapentin—migraine	0.000107	0.000369	CcSEcCtD
Gliclazide—Headache—Gabapentin—migraine	0.000106	0.000366	CcSEcCtD
Gliclazide—Hypersensitivity—Topiramate—migraine	0.000105	0.000363	CcSEcCtD
Gliclazide—Asthenia—Topiramate—migraine	0.000102	0.000353	CcSEcCtD
Gliclazide—Pruritus—Topiramate—migraine	0.000101	0.000348	CcSEcCtD
Gliclazide—Nausea—Gabapentin—migraine	0.000101	0.000347	CcSEcCtD
Gliclazide—Diarrhoea—Topiramate—migraine	9.76e-05	0.000337	CcSEcCtD
Gliclazide—Dizziness—Topiramate—migraine	9.43e-05	0.000325	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TNF—migraine	9.31e-05	0.00283	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—HTR3A—migraine	9.16e-05	0.00279	CbGpPWpGaD
Gliclazide—Vomiting—Topiramate—migraine	9.07e-05	0.000313	CcSEcCtD
Gliclazide—Rash—Topiramate—migraine	8.99e-05	0.00031	CcSEcCtD
Gliclazide—Dermatitis—Topiramate—migraine	8.98e-05	0.00031	CcSEcCtD
Gliclazide—Headache—Topiramate—migraine	8.93e-05	0.000308	CcSEcCtD
Gliclazide—Nausea—Topiramate—migraine	8.47e-05	0.000292	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—HTR1D—migraine	8.29e-05	0.00252	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—TNF—migraine	8.04e-05	0.00245	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—migraine	7.92e-05	0.00241	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR2B—migraine	7.7e-05	0.00235	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LRP1—migraine	6.78e-05	0.00206	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TNF—migraine	6.54e-05	0.00199	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOTCH4—migraine	5.2e-05	0.00158	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—migraine	5.19e-05	0.00158	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR1B—migraine	5.02e-05	0.00153	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR1A—migraine	4.83e-05	0.00147	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TAC1—migraine	4.76e-05	0.00145	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PGR—migraine	4.76e-05	0.00145	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NPS—migraine	4.76e-05	0.00145	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR2C—migraine	4.67e-05	0.00142	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EDNRA—migraine	4.54e-05	0.00138	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOTCH3—migraine	4.42e-05	0.00135	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CALCA—migraine	4.37e-05	0.00133	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR7—migraine	4.09e-05	0.00124	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MTHFR—migraine	3.74e-05	0.00114	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—migraine	3.7e-05	0.00113	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CACNA1A—migraine	3.65e-05	0.00111	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MTHFR—migraine	3.63e-05	0.0011	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFBR2—migraine	3.52e-05	0.00107	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CACNA1A—migraine	3.27e-05	0.000997	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CACNA1A—migraine	2.99e-05	0.000909	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR2A—migraine	2.86e-05	0.000872	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ESR1—migraine	2.54e-05	0.000774	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTHFR—migraine	1.21e-05	0.000367	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTHFR—migraine	1.08e-05	0.00033	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTHFR—migraine	9.88e-06	0.000301	CbGpPWpGaD
